Skip to content

EXCELSUS

Absorbed by SOPHARMA on 30-06-2025 KBO/BCE: BE 0886.339.775

Holdings

own 2024 accounts
This companyEXCELSUS1 holding, 1 country 2024 accounts
Since the merger of 30-06-2025, these holdings have been held by SOPHARMA.

Europe 1 Equity Result

  • NL 26.72% €0 result €0

Source: list of holdings in its own 2024 accounts. The amounts are in that list and come from the holdings' accounts at 31-12-2020, in their own currency.

Holdings and subsidiaries

1 holding

Holdings 1

Since the merger of 30-06-2025, these holdings have been held by .
Share, source and own figures per holding (1)
  • NL
    Equity €0Result €0
    26.72%
Holdings through the years 2022 to 2024
Holdings through the years
Name202220232024
26.72%

Source: list of holdings in its own accounts

Board mandates elsewhere

2 board mandates
Since the merger of 30-06-2025, has continued these mandates.
Board mandates of EXCELSUSEXCELSUS sits on their board2
Director
Founded in 2001 · total assets €172.1m (2025)
Director
Founded in 1977 · 48 FTE (2025)

Acquisitions and mergers

3 transactions
Taken over by:SOPHARMA
BE 0476.391.546merger by absorption · Gazette deed of 22-07-2025 (5 deeds) · according to the KBO register since 30-06-2025
Taken over by:Beukenlaan NV
BE 0437.826.524merger by absorption · proposal · Gazette deed of 22-11-2018 (2 deeds)
Split off to:ROBERTSVLEI
BE 0751.666.658partial demerger · Gazette deed of 10-08-2020 (2 deeds)

Connections & network

4 last directors
Depth

The board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.